RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ra Medical Systems Stock

Ra Medical Systems Market capitalization 2024

Ra Medical Systems Market capitalization

402,226 USD

Ticker

RMED

ISIN

US74933X2036

WKN

A2QJCG

In 2024, Ra Medical Systems's market cap stood at 402,226 USD, a -89.34% increase from the 3.77 M USD market cap in the previous year.

The Ra Medical Systems Market capitalization history

YEARMarket Capitalization (undefined USD)
20220.02
20210.02
20200.03
20190.05
20184.72
2017-
2016-

Ra Medical Systems Aktienanalyse

What does Ra Medical Systems do?

Ra Medical Systems Inc. is a California-based company specializing in the development and sale of medical devices for the treatment of vascular diseases. The company was founded in 2002 and is headquartered in Carlsbad. The company was founded by Dr. Dean Irwin and Dr. Melissa Burstein, both experts in laser therapy. The company initially focused on developing laser systems for the treatment of skin diseases. In 2016, the company changed its business strategy and shifted its focus to the development of medical devices for the treatment of vascular diseases. Since then, the company has become a leading provider of devices for the treatment of peripheral artery occlusive disease (PAOD) and other vascular diseases. The business model of Ra Medical Systems Inc. is based on selling high-tech medical devices and their corresponding accessories. The company sells its products directly to medical facilities and healthcare providers in the US and some international markets. The company also provides training, technical support, and service to ensure the safe and effective use of its products. Ra Medical Systems Inc. offers two main products: the DABRA™ System and the Pharos™ System. Both systems use pulsed laser therapy for the treatment of vascular diseases. The DABRA™ System is a laser system specifically designed for the treatment of peripheral artery occlusive disease (PAOD). It is the only FDA-approved system that offers atherectomy laser therapy. The system enables fast and safe treatment of blocked arteries and is less invasive than traditional surgical procedures. The DABRA™ System also has the potential to reduce the need for long-term medication and repeated procedures, which can lower treatment costs. The Pharos™ System is a laser system specifically designed for the treatment of skin diseases such as psoriasis, vitiligo, and atopic dermatitis. The system uses a high-energy dose to selectively destroy abnormal functioning tissue without affecting surrounding tissue. The Pharos™ System has the potential to improve the quality of life for patients with skin diseases and expand therapeutic options for this patient group. Ra Medical Systems Inc. also offers a complete accessory catalog for its products, including catheters and accessories for the DABRA™ System and handpieces and cooling devices for the Pharos™ System. In conclusion, Ra Medical Systems Inc. is a leading provider of medical devices for the treatment of vascular diseases and skin diseases. The company specializes in the development of high-tech laser systems that provide safe and effective procedures for patients and doctors. The DABRA™ System is a revolutionary laser system for the treatment of PAOD that has the potential to reduce the need for invasive surgical procedures and long-term medication. The Pharos™ System expands therapeutic options for patients with skin diseases and has the potential to improve the quality of life for this patient group. Ra Medical Systems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Ra Medical Systems's Market Capitalization

Ra Medical Systems's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Ra Medical Systems's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Ra Medical Systems's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Ra Medical Systems’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Ra Medical Systems stock

What is the current Ra Medical Systems market capitalization?

The current market capitalization of Ra Medical Systems is 402,226 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Ra Medical Systems.

How has the market capitalization of Ra Medical Systems developed in recent years?

The market capitalization of Ra Medical Systems has increased/decreased by -89.34% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Ra Medical Systems?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Ra Medical Systems?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Ra Medical Systems have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Ra Medical Systems pay?

Over the past 12 months, Ra Medical Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ra Medical Systems is expected to pay a dividend of 0 USD.

What is the dividend yield of Ra Medical Systems?

The current dividend yield of Ra Medical Systems is .

When does Ra Medical Systems pay dividends?

Ra Medical Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ra Medical Systems?

Ra Medical Systems paid dividends every year for the past 0 years.

What is the dividend of Ra Medical Systems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ra Medical Systems located?

Ra Medical Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ra Medical Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ra Medical Systems from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Ra Medical Systems pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Ra Medical Systems in the year 2023?

In the year 2023, Ra Medical Systems distributed 0 USD as dividends.

In which currency does Ra Medical Systems pay out the dividend?

The dividends of Ra Medical Systems are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ra Medical Systems

Our stock analysis for Ra Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ra Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.